FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Tagen

Research Profile

Anatomy

Mast Cells

Chemicals & Drugs

Living Beings

Concepts & Ideas

Procedures

Disorders

Co-author Network

Publications

TOP 3
Susan M Blaney; Jim Boyett; Stewart Goldman; Sridharan Gururangan; Mark W Kieran; Larry Kun; Arzu Onar-Thomas; Kathleen Scorsone; Jack Su; Michael Tagen; Stacey L Berg; Clinton Stewart
A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.
Ibrahim Qaddoumi; Carlos Rodriguez-Galindo; Clinton F Stewart; Michael Tagen; Jianrong Wu; Catherine A Billups; Rachel Brennan; Tammy M Free; Vicki Given; Barrett G Haik; Kathleen J Helton; M Beth McCarville; Thomas E Merchant; Matthew W Wilson
Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity.
Steven G DuBois; Fariba Goodarzian; Susan Groshen; Randall Hawkins; Araz Marachelian; John M Maris; Yael P Mosse; Hiroyuki Shimada; Clinton Stewart; Michael Tagen; Denice Tsao-Wei; Judith G Villablanca; Gregory Yanik; Louis Chesler; Katherine K Matthay
Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Tagen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Susan M Blaney; Jim Boyett; Stewart Goldman; Sridharan Gururangan; Mark W Kieran; Larry Kun; Arzu Onar-Thomas; Kathleen Scorsone; Jack Su; Michael Tagen; Stacey L Berg; Clinton Stewart
A phase-1 pharmacokinetic optimal dosing study of intraventricular topotecan for children with neoplastic meningitis: a Pediatric Brain Tumor Consortium study.
Pediatric blood & cancer 2013;60(4):627-32.
2012: Ibrahim Qaddoumi; Carlos Rodriguez-Galindo; Clinton F Stewart; Michael Tagen; Jianrong Wu; Catherine A Billups; Rachel Brennan; Tammy M Free; Vicki Given; Barrett G Haik; Kathleen J Helton; M Beth McCarville; Thomas E Merchant; Matthew W Wilson
Topotecan and vincristine combination is effective against advanced bilateral intraocular retinoblastoma and has manageable toxicity.
Cancer 2012;118(22):5663-70.
2012: Steven G DuBois; Fariba Goodarzian; Susan Groshen; Randall Hawkins; Araz Marachelian; John M Maris; Yael P Mosse; Hiroyuki Shimada; Clinton Stewart; Michael Tagen; Denice Tsao-Wei; Judith G Villablanca; Gregory Yanik; Louis Chesler; Katherine K Matthay
Phase I study of vincristine, irinotecan, and ¹³¹I-metaiodobenzylguanidine for patients with relapsed or refractory neuroblastoma: a new approaches to neuroblastoma therapy trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(9):2679-86.
2011: Mohamed A Elmeliegy; Angel M Carcaboso; Michael Tagen; Feng Bai; Clinton F Stewart
Role of ATP-binding cassette and solute carrier transporters in erlotinib CNS penetration and intracellular accumulation.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(1):89-99.
2011: Fan Zhang; Michael Tagen; Stacy Throm; Jeremy Mallari; Laura Miller; R Kiplin Guy; Michael A Dyer; Richard T Williams; Martine F Roussel; Katie Nemeth; Fangyi Zhu; Jiakun Zhang; Min Lu; John C Panetta; Nidal Boulos; Clinton F Stewart
Whole-body physiologically based pharmacokinetic model for nutlin-3a in mice after intravenous and oral administration.
Drug metabolism and disposition: the biological fate of chemicals 2011;39(1):15-21.
2010: Michael Tagen; Yanli Zhuang; Fan Zhang; K Elaine Harstead; Jun Shen; Paula Schaiquevich; Charles H Fraga; John C Panetta; Christopher M Waters; Clinton F Stewart
P-glycoprotein, but not multidrug resistance protein 4, plays a role in the systemic clearance of irinotecan and SN-38 in mice.
Drug metabolism letters 2010;4(4):195-201.
2010: Duraisamy Kempuraj; Pio Conti; Magdalini Vasiadi; Konstantinos-Dionysios Alysandratos; Michael Tagen; Dimitrios Kalogeromitros; Taxiarchis Kourelis; Stamatios Gregoriou; Michael Makris; Nikolaos G Stavrianeas; Theoharis C Theoharides
IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells.
European journal of dermatology : EJD 2010;20(6):865-7.
2010: Alberto Broniscer; Justin N Baker; Michael Tagen; Arzu Onar-Thomas; Richard J Gilbertson; Andrew M Davidoff; Atmaram S Pai Panandiker; Atmaram Pai Panandiker; Wing Leung; Thomas K Chin; Clinton F Stewart; Mehmet Kocak; Christopher Rowland; Thomas E Merchant; Sue C Kaste; Amar Gajjar
Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(31):4762-8.
2010: Feng Bai; Michael Tagen; Courtney Colotta; Laura Miller; Maryam Fouladi; Clinton F Stewart
Determination of the gamma-secretase inhibitor MK-0752 in human plasma by online extraction and electrospray tandem mass spectrometry (HTLC-ESI-MS/MS).
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2010;878(25):2348-52.
2010: Trevor McKibbin; Wei Zhao; Michael Tagen; Najat C Daw; Wayne L Furman; Lisa M McGregor; J Russell Geyer; Jeffrey W Allen; Clinton F Stewart
Epidermal growth factor receptor polymorphisms and risk for toxicity in paediatric patients treated with gefitinib.
European journal of cancer (Oxford, England : 1990) 2010;46(11):2045-51.
2010: K Elaine Hubbard; Amy Wells; Thandranese S Owens; Michael Tagen; Charles H Fraga; Clinton F Stewart
Determination of dopamine, serotonin, and their metabolites in pediatric cerebrospinal fluid by isocratic high performance liquid chromatography coupled with electrochemical detection.
Biomedical chromatography : BMC 2010;24(6):626-31.
2010: Feng Bai; Fangyi Zhu; Michael Tagen; Laura Miller; Thandranese S Owens; Jeremy Mallari; Edward Derrick; Fan Zhang; Clinton F Stewart
Determination of nutlin-3a in murine plasma by liquid chromatography electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS).
Journal of pharmaceutical and biomedical analysis 2010;51(4):915-20.
2010: Bodi Zhang; Zhang Bodi; Duraisamy Kempuraj; Michael Tagen; Magdalini Vasiadi; Asimenia Angelidou; Konstantinos-Dionysios Alysandratos; Dimitris Kalogeromitros; shahrzad asadi; Nikolaos G Stavrianeas; Erika Peterson; Susan Leeman; Pio Conti
IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.
Proceedings of the National Academy of Sciences of the United States of America 2010;107(9):4448-53.
2010: Rachel Kennedy; Daniel Groepper; Michael Tagen; Robbin Christensen; Fariba Navid; Amar Gajjar; Clinton F Stewart
Stability of cyclophosphamide in extemporaneous oral suspensions.
The Annals of pharmacotherapy 2010;44(2):295-301.
2009: Michael Tagen; Alvaro Elorza; Duraisamy Kempuraj; William Boucher; Christopher L Kepley; orian shirihai; Theoharis C Theoharides
Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(10):6313-9.
2009: Jun Shen; Angel M Carcaboso; K Elaine Hubbard; Michael Tagen; Henry G Wynn; John C Panetta; Christopher M Waters; Mohamed A Elmeliegy; Clinton F Stewart
Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid.
Cancer research 2009;69(14):5885-92.
2009: Feng Bai; Charles H Fraga; Michael Tagen; Paula Schaiquevich; Nikolaus Hagedorn; Clinton F Stewart
Simultaneous determination of cyclophosphamide and carboxyethylphosphoramide mustard in human plasma using online extraction and electrospray tandem mass spectrometry (HTLC-ESI-MS/MS).
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2009;877(18-19):1709-15.
2008: Duraisamy Kempuraj; Michael Tagen; B P Iliopoulou; A Clemons; Magdalini Vasiadi; William Boucher; M House; A Wolfberg; Theoharis C Theoharides
Luteolin inhibits myelin basic protein-induced human mast cell activation and mast cell-dependent stimulation of Jurkat T cells.
British journal of pharmacology 2008;155(7):1076-84.
2007: Maria Luisa Castellani; K Bhattacharya; Michael Tagen; Duraisamy Kempuraj; Alessandro Perrella; Maria Anna De Lutiis; William Boucher; Pio Conti; Theoharis C Theoharides; G Cerulli; Vincenzo Salini; G Neri
Anti-chemokine therapy for inflammatory diseases.
International journal of immunopathology and pharmacology 2007;20(3):447-53.
2007: Michael Tagen; Linsey Stiles; Dimitrios Kalogeromitros; Stamatis Gregoriou; Duraisamy Kempuraj; Michael Makris; Jill Donelan; Magdalini Vasiadi; Nikolaos G Staurianeas; Theoharis C Theoharides
Skin corticotropin-releasing hormone receptor expression in psoriasis.
The Journal of investigative dermatology 2007;127(7):1789-91.
2007: Theoharis C Theoharides; Duraisamy Kempuraj; Michael Tagen; Pio Conti; Dimitrios Kalogeromitros
Differential release of mast cell mediators and the pathogenesis of inflammation.
Immunological reviews 2007;217():65-78.
2007: Pio Conti; Maria Luisa Castellani; Duraisamy Kempuraj; Vincenzo Salini; Jacopo Vecchiet; Stefano Tetè; Filiberto Mastrangelo; Alessandro Perrella; Maria Anna De Lutiis; Michael Tagen; Theoharis C Theoharides
Role of mast cells in tumor growth.
Annals of clinical and laboratory science 2007;37(4):315-22.
2007: Maria Luisa Castellani; Alessandro Perrella; Duraisamy Kempuraj; William Boucher; Michael Tagen; Vincenzo Salini; Jacopo Vecchiet; Stefano Tetè; Stavros Frydas; Theoharis C Theoharides; Pio Conti
Immunological activation of human umbilical cord blood mast cells induces tryptase secretion and interleukin-6, and histidine decarboxilase mRNA gene expression.
Pharmacological research : the official journal of the Italian Pharmacological Society 2007;55(1):57-63.
2006: Maria Luisa Castellani; Vincenzo Salini; Stavros Frydas; Jill Donelan; Michael Tagen; Bhuvaneshwari Madhappan; Claudia Petrarca; Katia Falasca; G Neri; S Tete; Jacopo Vecchiet
The proinflammatory interleukin-21 elicits anti-tumor response and mediates autoimmunity.
International journal of immunopathology and pharmacology 2006;19(2):247-51.
2006: Theoharis C Theoharides; D Kempuraj; Michael Tagen; Magdalini Vasiadi; Curtis L Cetrulo
Human umbilical cord blood-derived mast cells: a unique model for the study of neuro-immuno-endocrine interactions.
Stem cell reviews 2006;2(2):143-54.
2005: Theoharis C Theoharides; Dean Papaliodis; Michael Tagen; Aphrodite Konstantinidou; Duraisamy Kempuraj; Anthony Clemons
Chronic fatigue syndrome, mast cells, and tricyclic antidepressants.
Journal of clinical psychopharmacology 2005;25(6):515-20.
2005: Michael Tagen; Margery C Beinfeld
Recombinant prohormone convertase 1 and 2 cleave purified pro cholecystokinin (CCK) and a synthetic peptide containing CCK 8 Gly Arg Arg and the carboxyl-terminal flanking peptide.
Peptides 2005;26(12):2530-5.